Latest News in Ophthalmology Research
- UI vision researchers receive funding from Foundation Fighting Blindness. Edwin M. Stone, MD, PhD and colleagues have received a five-year, $1.6 million grant from the Foundation Fighting Blindness. The funding will support the Research Center for the Study of Retinal Degeneration, which is part of the UI Institute for Vision Research. The group will focus on identifying new causes of inherited retinal disease and exploring the mechanism and course of the diseases. (9-15-2011)
- UI vision researcher receives funding for macular degeneration study Vinit Mahajan, M.D., Ph.D., has received a two-year, $100,000 grant from the American Health Assistance Foundation to investigate the role of inflammatory proteins in age-related macular degeneration (8-26-2011)
- UI research team finds new genetic cause of blinding eye disease Combining the expertise of several different labs, University of Iowa researchers have found a new genetic cause of the blinding eye disease retinitis pigmentosa (RP) and, in the process, discovered an entirely new version of the message that codes for the affected protein. For the full story go to: http://news-releases.uiowa.edu/2011/august/080911eye_disease_gene.html (8-10-2011)
- Retinal Camera aims to reduce blindness. Physicians and researchers at the University of Iowa are developing retina screening techniques and imaging cameras that are able to detect diabetic retinopathy as well as other diseases and conditions. The new technology expands the availability of vision screening and reduces the cost of eye care resulting from diabetes. (6-30-2011)
- Research to Prevent Blindness awards grants to two UI vision researchers. Vinit Mahajan, M.D., Ph.D. received a career development award and Markus Kuehn, Ph.D was awarded a special scholar award from the organization, Research to Prevent Blindness. Read more at: http://www.news-releases.uiowa.edu/2011/June/062311at-a-glance.html
- Tucker describes stem-cell retina regeneration. UI vision researcher, Budd Tucker, comments on how induced pluripotent stem cells hold great promise for future treatment and cures for diseases such as age-related macular degeneration, retinitis pigmentosa and other retinal diseases. (5-16-2011)
- Abramoff honored from innovation in telemedicine. The American Telemedicine Association (ATA) has named Michael D. Abramoff, MD, PhD, as a co-winner of the 2011 President’s Award for the Advancement of Telemedicine for Innovation. Dr. Abramoff, along with the other award co-winner, Hubble Telemedical, is being recognized for his innovative approaches in the automated detection of Diabetic Retinopathy. (5-6-2011)
- Study finds Avastin, Lucentis equally effective for age-related macular degeneration. Eye researchers, including James Folk, MD at the University of Iowa, are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.(4-29-2011)
- Sheffield VC, Stone EM. Genomics and the Eye. New Engl J Med 2011;364:1932-1942 (full text)
- Destiny and DNA, by Kathryn Howe
Iowa Alumni Magazine, June 2010
Last modified on Thursday, 15 September 2011 11:39
